SC
WX

Sculptor Capital’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Sculptor Capital’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-1,713,645
Closed -$74M – 492
2015
Q3 		$74M Buy
1,713,645
+830,255
+94% +$35M 0.26% 80
2015
Q2 		$37.3M Buy
+883,390
New +$37.3M 0.11% 122

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Sculptor Capital's WX Position: Q4 2015 in Review

Sculptor Capital sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 1,713,645 shares — an estimated $74M sold.

Sculptor Capital first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $74M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Sculptor Capital reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Sculptor Capital sold 1,713,645 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $74M.
  • Sculptor Capital first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
  • Sculptor Capital's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $74M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Sculptor Capital's 13F filing for Q4 2015, filed 16 Feb 2016.